Application of Proteomics in Maternal and Neonatal Health: Advancements and Future Directions
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1867003076857036801 |
|---|---|
| author | Razan Elkahlout Sawsan G. A. A. Mohammed Ahmed Najjar Thomas Farrell Hilal Al Rifai Nader Al‐Dewik M. Walid Qoronfleh |
| author_facet | Razan Elkahlout Sawsan G. A. A. Mohammed Ahmed Najjar Thomas Farrell Hilal Al Rifai Nader Al‐Dewik M. Walid Qoronfleh Razan Elkahlout Sawsan G. A. A. Mohammed Ahmed Najjar Thomas Farrell Hilal Al Rifai Nader Al‐Dewik M. Walid Qoronfleh |
| collection | Wiley Open Access |
| contents | Application of Proteomics in Maternal and Neonatal Health: Advancements and Future Directions Razan Elkahlout Sawsan G. A. A. Mohammed Ahmed Najjar Thomas Farrell Hilal Al Rifai Nader Al‐Dewik M. Walid Qoronfleh PROTEOMICS – Clinical Applications ABSTRACTMaternal and neonatal health (women during pregnancy, childbirth, and the postnatal period) presents a spectrum of healthcare challenges, including preterm birth, preeclampsia, intrauterine growth restriction, polycystic ovarian syndrome, and gestational diabetes mellitus. While genomic investigations have shed light on many of these topics, protein biomarker discovery, a pivotal aspect of such research, holds promise in offering insights into disease diagnosis, progression, and prognosis. This review paper aims to explore the landscape of proteomics research pertaining to the aforementioned disorders. In the search for viable biomarkers, existing ones are either outdated or lack specificity and new ones being investigated do not commonly make it to the validation stage. In this review, the reasons for the gap between the biomarker discovery stage and the clinical validation stage are evaluated, in addition to what steps are being taken to mitigate the unexpectedly slow scientific and clinical progress. Notably, this paper also delves into the ethnic disparities found in maternal and neonatal health research, as well as how AI is currently being used to alleviate socioeconomic and ethnic disparities, as well as its advantages for the analysis of large “omics” datasets. We anticipate this investigation will provide critical, invaluable information for researchers, medical professionals, and policy decision‐makers in this field to improve overall maternal and neonatal health outcomes. 10.1002/prca.70004 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1002/prca.70004 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_prca_70004 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2025 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Application of Proteomics in Maternal and Neonatal Health: Advancements and Future Directions Razan Elkahlout Sawsan G. A. A. Mohammed Ahmed Najjar Thomas Farrell Hilal Al Rifai Nader Al‐Dewik M. Walid Qoronfleh PROTEOMICS – Clinical Applications Application of Proteomics in Maternal and Neonatal Health: Advancements and Future Directions Razan Elkahlout Sawsan G. A. A. Mohammed Ahmed Najjar Thomas Farrell Hilal Al Rifai Nader Al‐Dewik M. Walid Qoronfleh PROTEOMICS – Clinical Applications ABSTRACTMaternal and neonatal health (women during pregnancy, childbirth, and the postnatal period) presents a spectrum of healthcare challenges, including preterm birth, preeclampsia, intrauterine growth restriction, polycystic ovarian syndrome, and gestational diabetes mellitus. While genomic investigations have shed light on many of these topics, protein biomarker discovery, a pivotal aspect of such research, holds promise in offering insights into disease diagnosis, progression, and prognosis. This review paper aims to explore the landscape of proteomics research pertaining to the aforementioned disorders. In the search for viable biomarkers, existing ones are either outdated or lack specificity and new ones being investigated do not commonly make it to the validation stage. In this review, the reasons for the gap between the biomarker discovery stage and the clinical validation stage are evaluated, in addition to what steps are being taken to mitigate the unexpectedly slow scientific and clinical progress. Notably, this paper also delves into the ethnic disparities found in maternal and neonatal health research, as well as how AI is currently being used to alleviate socioeconomic and ethnic disparities, as well as its advantages for the analysis of large “omics” datasets. We anticipate this investigation will provide critical, invaluable information for researchers, medical professionals, and policy decision‐makers in this field to improve overall maternal and neonatal health outcomes. 10.1002/prca.70004 http://creativecommons.org/licenses/by/4.0/ |
| title | Application of Proteomics in Maternal and Neonatal Health: Advancements and Future Directions |
| topic | PROTEOMICS – Clinical Applications |
| url | https://onlinelibrary.wiley.com/doi/10.1002/prca.70004 |